- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 319/02 - 1,2-DioxanesHydrogenated 1,2-dioxanes
Patent holdings for IPC class C07D 319/02
Total number of patents in this class: 9
10-year publication summary
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10104 |
1 |
| Sumitomo Chemical Company, Limited | 8964 |
1 |
| The Board of Trustees of the University of Illinois | 2682 |
1 |
| Arkema France | 3890 |
1 |
| Sage Therapeutics, Inc. | 349 |
1 |
| Teva Pharmaceutical Industries Ltd. | 808 |
1 |
| Teva Pharmaceuticals USA, Inc. | 938 |
1 |
| Universidad Autonoma Metropolitana | 22 |
1 |
| Université Paris-saclay | 503 |
1 |
| Other owners | 0 |